Parenti G - Search Results

1

N-Butyl-l-deoxynojirimycin (l-NBDNJ): Synthesis of an Allosteric Enhancer of α-Glucosidase Activity for the Treatment of Pompe Disease.

D'Alonzo D, De Fenza M, Porto C, Iacono R, Huebecker M, Cobucci-Ponzano B, Priestman DA, Platt F, Parenti G, Moracci M, Palumbo G, Guaragna A. D'Alonzo D, et al. Among authors: parenti g. J Med Chem. 2017 Dec 14;60(23):9462-9469. doi: 10.1021/acs.jmedchem.7b00646. Epub 2017 Nov 22. J Med Chem. 2017. PMID: 29112434

2

Pharmacological enhancement of mutated alpha-glucosidase activity in fibroblasts from patients with Pompe disease.

Parenti G, Zuppaldi A, Gabriela Pittis M, Rosaria Tuzzi M, Annunziata I, Meroni G, Porto C, Donaudy F, Rossi B, Rossi M, Filocamo M, Donati A, Bembi B, Ballabio A, Andria G. Parenti G, et al. Mol Ther. 2007 Mar;15(3):508-14. doi: 10.1038/sj.mt.6300074. Epub 2007 Jan 9. Mol Ther. 2007. PMID: 17213836 Free article.

3

Long-term enzyme replacement therapy for pompe disease with recombinant human alpha-glucosidase derived from chinese hamster ovary cells.

Rossi M, Parenti G, Della Casa R, Romano A, Mansi G, Agovino T, Rosapepe F, Vosa C, Del Giudice E, Andria G. Rossi M, et al. Among authors: parenti g. J Child Neurol. 2007 May;22(5):565-73. doi: 10.1177/0883073807302598. J Child Neurol. 2007. PMID: 17690063 Clinical Trial.

4

Abnormal mannose-6-phosphate receptor trafficking impairs recombinant alpha-glucosidase uptake in Pompe disease fibroblasts.

Cardone M, Porto C, Tarallo A, Vicinanza M, Rossi B, Polishchuk E, Donaudy F, Andria G, De Matteis MA, Parenti G. Cardone M, et al. Among authors: parenti g. Pathogenetics. 2008 Dec 1;1(1):6. doi: 10.1186/1755-8417-1-6. Pathogenetics. 2008. PMID: 19046416 Free PMC article.

5

The pharmacological chaperone N-butyldeoxynojirimycin enhances enzyme replacement therapy in Pompe disease fibroblasts.

Porto C, Cardone M, Fontana F, Rossi B, Tuzzi MR, Tarallo A, Barone MV, Andria G, Parenti G. Porto C, et al. Among authors: parenti g. Mol Ther. 2009 Jun;17(6):964-71. doi: 10.1038/mt.2009.53. Epub 2009 Mar 17. Mol Ther. 2009. PMID: 19293774 Free PMC article.

6

The pharmacological chaperone 1-deoxynojirimycin increases the activity and lysosomal trafficking of multiple mutant forms of acid alpha-glucosidase.

Flanagan JJ, Rossi B, Tang K, Wu X, Mascioli K, Donaudy F, Tuzzi MR, Fontana F, Cubellis MV, Porto C, Benjamin E, Lockhart DJ, Valenzano KJ, Andria G, Parenti G, Do HV. Flanagan JJ, et al. Among authors: parenti g. Hum Mutat. 2009 Dec;30(12):1683-92. doi: 10.1002/humu.21121. Hum Mutat. 2009. PMID: 19862843

7

Synergy between the pharmacological chaperone 1-deoxygalactonojirimycin and the human recombinant alpha-galactosidase A in cultured fibroblasts from patients with Fabry disease.

Porto C, Pisani A, Rosa M, Acampora E, Avolio V, Tuzzi MR, Visciano B, Gagliardo C, Materazzi S, la Marca G, Andria G, Parenti G. Porto C, et al. Among authors: parenti g. J Inherit Metab Dis. 2012 May;35(3):513-20. doi: 10.1007/s10545-011-9424-3. Epub 2011 Dec 21. J Inherit Metab Dis. 2012. PMID: 22187137

8

Enzyme replacement therapy in patients with Fabry disease: state of the art and review of the literature.

Pisani A, Visciano B, Roux GD, Sabbatini M, Porto C, Parenti G, Imbriaco M. Pisani A, et al. Among authors: parenti g. Mol Genet Metab. 2012 Nov;107(3):267-75. doi: 10.1016/j.ymgme.2012.08.003. Epub 2012 Aug 11. Mol Genet Metab. 2012. PMID: 22963910 Review.

9

Pharmacological enhancement of α-glucosidase by the allosteric chaperone N-acetylcysteine.

Porto C, Ferrara MC, Meli M, Acampora E, Avolio V, Rosa M, Cobucci-Ponzano B, Colombo G, Moracci M, Andria G, Parenti G. Porto C, et al. Among authors: parenti g. Mol Ther. 2012 Dec;20(12):2201-11. doi: 10.1038/mt.2012.152. Epub 2012 Sep 18. Mol Ther. 2012. PMID: 22990675 Free PMC article.

10

Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease.

Spampanato C, Feeney E, Li L, Cardone M, Lim JA, Annunziata F, Zare H, Polishchuk R, Puertollano R, Parenti G, Ballabio A, Raben N. Spampanato C, et al. Among authors: parenti g. EMBO Mol Med. 2013 May;5(5):691-706. doi: 10.1002/emmm.201202176. Epub 2013 Apr 18. EMBO Mol Med. 2013. PMID: 23606558 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

401 results

Search Page